drug · small molecule
DAPSONE
Marketedupdated 3mo agoby Pulmonem Inc🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 7 investigational indications.
targets
Dihydropteroate synthase
all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 18, 2033
~7.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Nov 18, 2033formulationUS 11273132
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 54m ago
Found something off?
comments(0)
5-min edit window · permanent after that